share_log

MBX Biosciences | SC 13D: Statement of acquisition of beneficial ownership by individuals-OrbiMed Advisors LLC(12.0%),OrbiMed Capital GP VII LLC(9.9%), etc.

SEC ·  Sep 23, 2024 16:38
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more